Innovative Medical (002173.SZ) Announces Stock Volatility: Boling Brain-Computer Interface Products Not Yet Commercially Launched

Zhitong Finance APP News, Zhejiang Shanxiahu Pearl Group Co., Ltd. (002173.SZ) announced in its stock price fluctuation report that at the beginning of 2021, the company participated in the investment to establish Cereblink (Hangzhou) Technology Co., Ltd. (referred to as "Cereblink"), holding 40% of Cereblink's equity. Cereblink mainly engages in the core technology research and development of brain-computer interfaces and the design and production of related products. The current technical products are primarily applied in the medical rehabilitation field. As of the announcement date, Cereblink’s products have not yet been officially launched on the market, with only a small number of products sold due to collaborations with research institutions. In 2023 and 2024, Cereblink's operating losses were RMB 6.6017 million and RMB 8.6641 million, respectively.